Delivery Order SPE2DR25D1022-SPE2DR26FQS4M
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for Oseltamivir Phosphate 75 mg capsules in unit dose packaging. The contract, valued at $1,099.36, represents a firm fixed price delivery order with an ultimate completion date of December 16, 2025. This award was not set aside for small business or other socioeconomic categories and was competitively awarded. The place of performance is AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10 units. This contract, issued under a firm fixed-price delivery order structure, carries a ceiling value of $1,038.01 and is scheduled for completion by December 11, 2025. The award represents a non-competitive set-aside and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $31,839.30 to AmerisourceBergen Drug Corp for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10 units. This is a firm fixed price, competitively awarded delivery order with an ultimate completion date of December 3, 2025. The contract will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order was executed under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10 on December 16, 2025. This firm fixed price delivery order, valued at $2,776.22, is scheduled for completion by December 17, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The award utilized no set-aside designation and was made competitively. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit dose packaging (10s) under a firm fixed-price contract with a ceiling value of $3,121.50. The order was issued on November 10, 2025, with an ultimate completion date of November 12, 2025. AmerisourceBergen will perform this delivery order from its corporate office location in Conshohocken, Pennsylvania. This award represents a non-set-aside, competitively...
- The Defense Logistics Agency awarded a delivery order valued at $1,388.84 to AmerisourceBergen Drug Corp on December 18, 2025, for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packaging (10s). The contract, which is a firm fixed-price delivery order with no set-aside designation, represents a competitively awarded procurement and is scheduled for completion by December 19, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $2,081.00 to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit dose packaging (10s) on December 16, 2025, with an ultimate completion date of December 17, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 18, 2025, for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10 units, with a ceiling value of $1,889.21 and an ultimate completion date of December 19, 2025. This firm fixed price delivery order carries no set-aside designation and represents a competitive award under AmerisourceBergen's existing contract vehicle with DLA. The place of performance is listed as...
- The Defense Logistics Agency awarded a delivery order valued at $3,751.97 to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10 on December 11, 2025, with a completion date of December 12, 2025. This non-competitive delivery order represents a firm fixed price transaction performed at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Oseltamivir Phosphate 75 mg capsules (100-count packages) with a ceiling value of $1,890.00. This firm fixed-price delivery order is set to be completed by December 12, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a competitive award with no set-aside designation, issued under...
- SPE2DR25D1022Indefinite Delivery Contract
- SPE2DR25D1022-SPE2DR26FQS4MDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 17, 2025, for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packaging of 10s, with a ceiling value of $2,820.63 and an ultimate completion date of December 18, 2025. This is a firm fixed-price, non-set-aside delivery order performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion pharmaceutical prime vendor contract running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains a significant federal contract portfolio with the DLA and its Medical Supply Chain, delivering medications across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This particular delivery order for antiviral medication reflects the company's ongoing role as a critical vendor for federal medical procurement needs, supplying both brand-name and generic medications to military and veteran healthcare systems through competitively awarded contracts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 12/16/25 |